<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:dc="http://purl.org/dc/elements/1.1/">

<channel>
<title>Dusa Company Newsfeed</title>
<link>http://www.advfn.com/nasdaq/rss.asp?symbol=DUSA</link>
<description>Dusa Company Newsfeed</description>
<language>en</language>
<pubDate>Thu, 08 Nov 2012 07:48:40 EST</pubDate>
<lastBuildDate>Thu, 08 Nov 2012 07:48:40 EST</lastBuildDate>
  
  
 <item>
 <title>Sun Pharma Agrees to Buy Dermatology Company Dusa for $215 Million</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=DUSA&amp;article=54920828&amp;headline=sun-pharma-agrees-to-buy-dermatology-company-dusa-for-215-million</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=DUSA&amp;article=54920828&amp;headline=sun-pharma-agrees-to-buy-dermatology-company-dusa-for-215-million</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Saabira Chaudhuri &#60;/pre&#62;
&#60;p&#62; Sun Pharmaceutical Industries Ltd. (524715.BY, SPCEF) has agreed to buy U.S. dermatology company Dusa Pharmaceuticals Inc. (DUSA) for about $215 million in cash as the India-based company looks to make a foray into the lucrative market for dermatological...</description>
 <pubDate>Thu, 08 Nov 2012 07:48:40 EST</pubDate>
 </item>

</channel>
</rss>